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Genetically-encoded biosensors are powerful tools for understanding cellular signal
transduction mechanisms. In aiming to investigate cGMP signaling in neurones using
the EGFP-based fluorescent biosensor, FlincG (fluorescent indicator for cGMP), we
encountered weak or non-existent fluorescence after attempted transfection with plasmid
DNA, even in HEK293T cells. Adenoviral infection of HEK293T cells with FlincG, however,
had previously proved successful. Both constructs were found to harbor a mutation in
the EGFP domain and had a tail of 17 amino acids at the C-terminus that differed from
the published sequence. These discrepancies were systematically examined, together
with mutations found beneficial for the related GCaMP family of Ca2+ biosensors, in
a HEK293T cell line stably expressing both nitric oxide (NO)-activated guanylyl cyclase
and phosphodiesterase-5. Restoring the mutated amino acid improved basal fluorescence
whereas additional restoration of the correct C-terminal tail resulted in poor cGMP sensing
as assessed by superfusion of either 8-bromo-cGMP or NO. Ultimately, two improved
FlincGs were identified: one (FlincG2) had the divergent tail and gave moderate basal
fluorescence and cGMP response amplitude and the other (FlincG3) had the correct tail, a
GCaMP-like mutation in the EGFP region and an N-terminal tag, and was superior in both
respects. All variants tested were strongly influenced by pH over the physiological range,
in common with other EGFP-based biosensors. Purified FlincG3 protein exhibited a lower
cGMP affinity (0.89μM) than reported for the original FlincG (0.17μM) but retained rapid
kinetics and a 230-fold selectivity over cAMP. Successful expression of FlincG2 or FlincG3
in differentiated N1E-115 neuroblastoma cells and in primary cultures of hippocampal and
dorsal root ganglion cells commends them for real-time imaging of cGMP dynamics in
neural (and other) cells, and in their subcellular specializations.
Keywords: cGMP, genetically-encoded biosensor, nitric oxide, neuroblastoma, hippocampus, dorsal root ganglion,
C-type natriuretic peptide
INTRODUCTION
The development of relatively non-invasive, genetically-encoded
detectors that allow real-time imaging of secondmessengers, such
as Ca2+ and cyclic nucleotides, in living cells has greatly advanced
the understanding of cellular signal transduction (Tsien, 1998;
Mehta and Zhang, 2011). One cyclic nucleotide, cGMP, is found
in almost all cells where it serves as the secondmessenger for nitric
oxide (NO) and/or for peptide transmitters, including the natri-
uretic peptides. cGMP can engage multiple downstream path-
ways, including cGMP-dependent protein kinase (PKG), to bring
about acute or long-term alterations in cellular function. A num-
ber of cGMP biosensors that exploit Förster resonance energy
transfer have been engineered (Vincent et al., 2008; Thunemann
et al., 2013) but a particularly promising approach has capital-
ized on the success of the GCaMP family of Ca2+-sensitive, single
fluorescent proteins in which Ca2+-binding domains are fused
to circularly permuted EGFP (cpEGFP) (Nakai et al., 2001; Zhao
et al., 2011; Akerboom et al., 2012). The analogous cGMP biosen-
sor, called FlincG (standing for fluorescent indicator for cGMP;
specifically the δ-version; Nausch et al., 2008), incorporates a
cGMP-binding domain of PKG linked to cpEGFP. It shows 100-
fold or more selectivity over cAMP, is sensitive to submicromolar
concentrations of cGMP and displays rapid kinetics, allowing a
faithful readout of dynamic changes in cGMP within the physi-
ological range (Nausch et al., 2008; Batchelor et al., 2010; Wood
et al., 2011). Moreover, unlike the GCaMP series whose fluores-
cence is strongly influenced by pH (Nakai et al., 2001; Wang et al.,
2008; Zhao et al., 2011), FlincG is reported to be resistant to small
pH changes by virtue of having a low pKa of 6.1 (Nausch et al.,
2008).
Thus far, FlincG has been expressed in mammalian cells
mainly through the use of a serotype-5 adenoviral vector. This
method of delivery has proved successful in smooth muscle
cells, HEK293T cells and cardiac fibroblasts (Nausch et al., 2008;
Batchelor et al., 2010; Miller et al., 2011; Wood et al., 2011) but
it is unsuited to many other cell types of interest, such as neu-
rones, which lack the coxsackie and adenovirus receptor needed
to facilitate internalization (e.g., Lewis et al., 2010). A plasmid
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(pcDNA3.1) containing a δ-FlincG clone was provided to us by
the originator laboratory but, in attempts to transfect HEK293T
cells or primary neuronal cultures, little or no fluorescence above
background could be detected, suggesting a low level of FlincG
protein expression and/or lack of protein fluorescence.
In seeking an explanation for the poor performance of the
cGMP biosensor with conventional cDNA transfection compared
to adenoviral infection, we rescued the FlincG DNA from the
adenoviral genome and found disparities in both the plasmid
and adenoviral DNA compared with the published sequence.
The present report examines the importance of rectifying these
disparities for obtaining a usable FlincG plasmid and further
investigates the potential benefit of mutations in the cpEGFP
region that increased the baseline fluorescence and dynamic range
of GCaMP biosensors, as well as other sequence modifications.
MATERIALS AND METHODS
MATERIALS
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and car-
bonyl cyanide m-chlorophenylhydrazone (CCCP) were
from Tocris Bioscience; 2-(4-carboxyphenyl)-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (CPTIO), 1-hydroxy-2-
oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1-triazene (NOC-12),
8-bromo-cGMP, NG-nitro-L-arginine, Texas Red, proteinase-K,
nigericin, nerve growth factor, collagenase type XI, dispase and
superoxide dismutase were from Sigma-Aldrich; fluorescein
was from Millipore; (Z)-1-[N-(3-ammoniopropyl)-N-(n-
propyl)amino]diazen-1-ium-1,2-diolate] (PAPA/NO) was from
Enzo Life Sciences; FuGene and Lipofectamine were from
Promega and Invitrogen, respectively. Common laboratory
chemicals were from Sigma-Aldrich. Stock solutions of NOC-12
and PAPA/NO were made up in 10mM NaOH and kept on ice;
they were diluted 1000-fold into the experimental solution.
RESCUING FlincG DNA FROM pAd-DEST ADENOVIRAL VECTOR
The generation of pAd-DEST adenoviral vector containing
FlincG was described elsewhere (Nausch et al., 2008). This vec-
tor was isolated from adenoviral particles using the method of Le
et al. (2001). Briefly, adenoviral particles in tris-buffered saline
were treated with 1% SDS in the presence of proteinase-K. Vector
DNA was precipitated using ethanol after phenol-chloroform
extraction. To determine the sequence of adenoviral FlincG (AdV-
FlincG) DNA, it was subcloned from the recombinant adenoviral
genome into the pENTR1a vector using BP clonase (Invitrogen)
as per the manufacturer’s protocol. Briefly, 150 ng each of aden-
oviral DNA and pENTR1a were mixed with 2μl of BP clonase
and incubated at room temperature for 90min. The reaction was
treated with 20μg/ml proteinase-K and the DNA purified using
a Qiaquick column (Qiagen). The pENTR1a containing AdV-
FlincG DNA was propagated in E. coli DH5α cells selected for
kanamycin antibiotic resistance. The clones were verified by DNA
sequencing.
GENERATION OF FlincG MUTANTS
The AdV-FlincG DNA was located between BamHI and EcoRI
restriction sites. The DNA sequence between these two sites
had a partial Kozak sequence (ACCATGG) followed by the PKG
and cpEGFP regions, ending with a 17-amino acid “tail region”
(Figure 1A). The originating laboratory provided the same cDNA
sequence subcloned into the plasmid pcDNA3.1 (Nausch et al.,
2008). Approximately 850 surplus nucleotides beyond the stop
codon in both clones (coding for the catalytic domain of PKG)
were deleted in all variants included in this study, although in a
preliminary test with one variant (called FGB below), the trun-
cation made no obvious difference to its performance in imaging
experiments. Various point mutants containing tail A, tail B or
no tail were generated using either the overlapping primer exten-
sion method described by Liu and Naismith (2008) or using the
QuikChange II site-directed mutagenesis kit (Agilent Technology
Inc.) according to the manufacturer’s protocol. For cloning into
expression vectors, we used two plasmids, namely the pEGFP-
C1 vector (Clontech) with either a partial (ACCATGGCA) or full
(GCCACCATGGTA) Kozak consensus sequence, and the pTriEx-
4 vector which has the above partial Kozak sequence (Merck
Millipore). The 3′-terminal triplet of each Kozak sequence codes
for the second amino acid, which is alanine or valine (Figure S1),
the former being in the original adenoviral and plasmid-based
clones. As AdV-FlincG DNA gave poor basal fluorescence (see
Results), we initially speculated that this alanine might promote
protein degradation (Gonda et al., 1989) following normal post-
translational hydrolysis of the methionine in the first position and
so it was substituted for valine. Point mutations are denoted in the
text with a superscripted suffix indicating the single-letter code of
the mutated amino acid (see Figure 1). All mutations were ver-
ified by DNA sequencing using primers listed in Supplementary
Table 1.
PROTEIN PURIFICATION
One-liter cultures of Terrific Broth (Novagen), supplemented
with 4ml glycerol, 50μg/ml ampicillin and 50μg/ml chloram-
phenicol were prepared in UltraYield baffled flasks. The flasks
were inoculated with 10ml of an overnight culture of BL21
(DE3) cells harboring the pTriEx-4 vector with an N-terminal
hexahistidine-tagged FlincG variant. Cultures were grown at 37◦C
with shaking at 250 rpm. Induction was carried out at an OD600
of ∼3.5 with 0.5mM isopropylthio-β-galactoside and the cul-
tures were further incubated at 18◦C overnight at 250 rpm. The
next day, cells were harvested by centrifugation at 4◦C and the
pellets resuspended in two volumes per unit weight of lysis
buffer (50mM tris, 500mM NaCl, 5% glycerol, 5mM imidazole,
0.5mM tris(2-carboxyethyl)phosphine hydrochloride, pH 8.0).
Cells were lysed by sonic disruption and nucleic acids and cell
debris removed by adding polyethyleneimine to a final concen-
tration of 0.15%. The solution was clarified by centrifugation at
4◦C for 1 h at 25,000 g. Immobilized metal affinity chromatog-
raphy using a 5ml His-trap column (GE Healthcare) employed
the above-mentioned lysis buffer, supplemented with 30mM imi-
dazole. Bound protein was eluted in the same buffer with an
increased imidazole concentration (300mM). Finally, the eluted
protein was subjected to gel filtration on a Superdex 200 col-
umn (GE Healthcare) in 25mM tris (pH 8.0), 0.1M NaCl, 1mM
tris(2-carboxyethyl)phosphine hydrochloride and 5% glycerol.
Monomeric peak samples eluted from the gel were pooled and
concentrated to 25–30μM using Amicon spin filters (Ultracel
Frontiers in Molecular Neuroscience www.frontiersin.org September 2013 | Volume 6 | Article 26 | 2
Bhargava et al. cGMP biosensors
FIGURE 1 | Screening of FlincG variants. (A) Schematic diagram illustrating
the general FlincG design and specifying the modifications tested. The
diagram also defines the nomenclature adopted in text. (B) Brightfield (top)
and basal fluorescence (bottom) images of HEKGC/PDE5 cells 3 days after
attempted transfection with identical amounts (0.5μg/well) of AdV-FlincG
plasmid DNA (left) and FGB DNA (right). Scale bar = 100μm. (C) Sample
FACS spectra of suspensions of HEKGC/PDE5 cells transfected with the
indicated FlincG variants, before (black) and after (red) incubation with
8-bromo-cGMP (1mM). Calibration bars: vertical = frequency;
horizontal = log intensity (arbitrary units). Arrows and arrowheads indicate
untransfected and transfected components of the control spectra,
respectively. (D–F) Results of FACS analysis for groups of FlincG variants;
plasmids in panel D all bore a strong Kozak consensus sequence (see
Material and Methods). Numbers in parentheses are n-values.
PL-10, 10,000mW cut-off; Millipore). Protein was assayed using
the Bradford method. The concentrated protein was snap-frozen
in liquid nitrogen and stored at −80◦C until use.
SPECTROSCOPY
Excitation (emission at 510 nm) and emission spectra (excitation
at 490 nm) of purified N-terminal hexahistidine-tagged FlincG
proteins (10–30 nM) were recorded at room temperature through
the 1-cm light path of a 4-window, 1.5-ml quartz cuvette using the
Fluoromax-3 spectrofluorometer (Horiba Inc). To measure cyclic
nucleotide sensitivity, purified protein was added in a BHEK-
150 buffer containing BSA (0.3mg/ml), HEPES (30mM), EDTA
(20μM) and KCl (150mM), pH 7.4 (at room temperature),
osmolality 290–300 mosmol/kg. Inclusion of BSA and EDTA
in the buffer at the stated concentrations prevented artifactual
spectral changes during mixing; presumably, BSA blocked non-
specific protein interactions and EDTA chelated any free nickel
or other contaminating metal ions. Increasing concentrations of
cGMP, cAMP, or 8-Br-cGMP were added incrementally to gener-
ate concentration-response curves, the total ligand increasing the
volume by less than 1%. The mixtures were stirred magnetically
for more than 1min prior to spectral measurements. For testing
pH sensitivity, a pH titration buffer containing tri-sodium citrate
(30mM) and Tris-Cl (30mM) was used, its pH being adjusted
from 9 to 5 (at 0.5 intervals) usingHCl at room temperature. After
addition of BSA (0.3mg/ml), EDTA (20μM) and FlincG protein
(20–30 nM), fluorescence spectra were recorded before and after
addition of 100μM cGMP.
CELL CULTURE AND TRANSFECTION
HEK293T cells constitutively expressing NO-activated guany-
lyl cyclase and phosphodiesterase-5 were provided by Professor
Doris Koesling (University of Bochum, Germany). These
cells have been extensively characterized in previous studies
(Mullershausen et al., 2004; Batchelor et al., 2010; Wood et al.,
2011) and are referred to here as HEKGC/PDE5 cells. They
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were maintained and transfected as described (Batchelor et al.,
2010).
N1E-115 neuroblastoma cells (ATCC, Teddington, Middlesex,
UK) were cultured according to the supplier’s protocol in
a growth medium consisting of Dulbecco’s modified Eagle’s
medium (DMEM) containing L-glutamine and 4.5 g/l glu-
cose (Invitrogen) supplemented with NaHCO3 (1.5 g/l), fetal
bovine serum (10%) and penicillin/streptomycin (100U/ml and
100μg/ml, respectively), in a humidified, 5% CO2 atmosphere.
The cells were split at 70% confluency and the medium changed
every 2–3 days. For imaging, cells were plated onto poly-D-lysine-
coated glass coverslips in 24-well plates and were differentiated
by transfer into growth medium with 2% fetal bovine serum and
1.25% dimethylsulfoxide (Oh et al., 2005) for 3–4 days prior to
transfection using 1μg DNA/well and FuGene 6 (6μl/μg DNA).
Transfection was aided by briefly (4min) centrifuging the cul-
ture plates (128 g) at room temperature. The cultures were then
maintained for 3 days in growth medium lacking antibiotics and
containing 1% fetal bovine serum and 0.625% dimethylsulfoxide,
and for a further 3 days in normal differentiation medium, before
being used in experiments.
All animal use was approved by the local (UCL) ethics com-
mittee and was carried out strictly in accordance with the UK
Animals (Scientific Procedures) Act 1986. Mixed neurones from
newborn rat hippocampi were plated onto a feeder layer of astro-
cytes in 24-well plates according to published methods (Huettner
and Baughman, 1986; Morales et al., 2000). After 7–10 days the
medium was changed to an astrocyte-conditioned medium lack-
ing antibiotics and transfection (0.5μg DNA per well) was carried
out using FuGene 6 (3μl/μg DNA), facilitated by a brief centrifu-
gation (4min at 128 g) at room temperature. The cultures were
used for imaging 2–3 days later.
Dorsal root ganglion cells were isolated and cultured using
standard methods (Rugiero et al., 2010) with minor alter-
ations. Briefly, the ganglia were removed from 8-day-old
rats and digested in collagenase type XI (2.5mg/ml), dispase
(10mg/ml) and glucose (10mM) in Hank’s balanced salt solution
(Invitrogen) for 25min at 37◦C in 5% CO2. After the addi-
tion of DMEM containing 10% fetal bovine serum to stop the
digestion, cells were dissociated by trituration, collected by low-
speed centrifugation, and resuspended in antibiotic-free medium
composed of DMEM containing 1% glutamax, 10% fetal bovine
serum and 125 ng/ml nerve growth factor and then plated onto
glass coverslips pre-coated with poly-D-lysine (0.5mg/ml) and
laminin (0.02mg/ml). After allowing 30–60min at 37◦C for
attachment, the cells were transfected (0.5–1μg DNA per well)
with either FuGene 6 (3μl/μg DNA) or Lipofectamine 2000
(1μl/μg DNA). Plates were centrifuged (4min, 128 g) at room
temperature to aid transfection and were then incubated at 37◦C
in 5% CO2 for 2–3 days before use.
FLUORESCENCE-ACTIVATED CELL SORTER (FACS) ANALYSIS
HEKGC/PDE5 cells were transfected with 0.5μg DNA and 3μl
FuGene 6 per well, seeded into 12-well plates and cultured for
3 days, by which time they had reached confluency. The cells
were collected by trypsinization and resuspended into the buffer
used for cell imaging (see below). FACS analysis was performed
using a CyAn ADPHigh-Performance Flow Cytometer (Beckman
Coulter) equipped with a GFP filter (488 nm laser-line excita-
tion). A total of 12,000 gated events were sampled before and after
stimulation with 8-bromo-cGMP (1mM, 37◦C, 10min prein-
cubation). The same gates, set to exclude debris, dead cells and
cell clumps, were used throughout. The frequency-fluorescence
spectra displayed two distinct but overlapping peaks, representing
populations of untransfected and transfected cells (see Results).
The peaks were resolved by fitting the spectra in Mathcad 14
(Parametric Technology Corporation) to the sum of two asym-
metric double-sigmoidal functions of the following type:
y =
⎡
⎢⎢⎢⎢⎣A
⎡
⎢⎢⎢⎢⎣
1
1+exp
(
−
(
x− xc+ w12
)
w2
)
⎤
⎥⎥⎥⎥⎦
⎡
⎢⎢⎢⎢⎣1 −
1
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(
−
(
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w3
)
⎤
⎥⎥⎥⎥⎦
⎤
⎥⎥⎥⎥⎦
where A is the amplitude, xc the center, and w1, w2 and w3 are
widths. Values of the parameters were obtained byminimizing the
sum of the squares of the errors between data and fit, using the
“Minerr” function in Mathcad. Quantification of the peaks and
of the shifts brought about by 8-bromo-cGMP were carried out
as illustrated in the accompanying annotated Mathcad worksheet
(Supplementary Methods).
LIVE CELL IMAGING
Imaging was conducted using an inverted microscope as
described (Batchelor et al., 2010), with minor modifications. In
brief, glass coverslips with adhering cells were held in a chamber
(0.5ml volume) that was superfused continuously (1.5ml/min)
with warm (37◦C) solution containing: NaCl (136mM), KCl
(2mM), MgSO4 (1.2mM), KH2PO4 (1.2mM), CaCl2 (1.5mM),
glucose (5.5mM) and HEPES (10mM), pH 7.4. For delivery
of clamped NO concentrations, NG-nitro-L-arginine (30μM),
superoxide dismutase (100U/ml), CPTIO (0.1mM) and urate
(10μM for murine cells; 100μM for HEKGC/PDE5 cells), were
also included. With CPTIO and urate present, addition of the
slow NO releaser NOC-12 (half-life = 100min) produces fixed
NO concentrations that are proportional to the donor concen-
tration (Griffiths et al., 2003). NO was applied in this way either
by superfusion or from a nearby puffer pipette. With delivery by
superfusion, access of NO to the cells was quantified by superfus-
ing fluorescein (1 nM) at the end of the experiment. For puffer
application, Texas Red dye (10μM) was included in the pipette
solution and the NO concentration determined by dividing the
fluorescence intensity of the dye over the cell of interest by the
peak intensity found just outside the mouth of the pipette, which
was taken to be the same as the pipette concentration (1 nM
NO). Epifluorescent signals were captured by camera, corrected
for background, and displayed as the change in intensity relative
to baseline divided by the baseline intensity (F/F0).
STATISTICS AND CURVE FITTING
Values are presented as means ± SEM; n-values represent
numbers of independent experiments. Parameters describing
concentration-response curves together with their standard
Frontiers in Molecular Neuroscience www.frontiersin.org September 2013 | Volume 6 | Article 26 | 4
Bhargava et al. cGMP biosensors
errors were obtained from fits to the logistic equation in Origin
8.6 (OriginLab); pH parameters were derived from fits of titra-
tion curves (in Origin 8.6) to the following equation (Kneen et al.,
1998):
F = A + B
1 + 10nH(pKa ′−pH)
where F = fluorescence or change in fluorescence (F/F0),
nH = slope of the curve, pK′a = apparent pKa, A is the baseline
of the curve and B, the maximum signal above baseline.
RESULTS
FlincG ENGINEERING
DNA sequencing revealed that the adenoviral and plasmid-based
FlincGs were both point mutated (R349C; numbering as in AdV-
FlincG DNA; Figure S1) in the cpEGFP region. Also common to
both sequences, the codons of 17 amino acids in the “tail-region”
represented a sequence that mostly differed from the published
sequence. We call the tail of the published sequence “tail A” and
the divergent one “tail B” (Figure 1A). The effect of removing
the entire tail region was also examined. On top of these modi-
fications, we wished to test if incorporating one or both of two
mutations in the cpEGFP domain that led to improvements in a
related GCaMPCa2+ biosensor (Tian et al., 2009) have a similarly
beneficial effect on FlincGs. Accordingly, a matrix of alterations to
the tail region and the cpEGFP domain was generated and system-
atically tested using a HEK293T cell line stably expressing NO-
activated guanylyl cyclase and phosphodiesterase-5 (HEKGC/PDE5
cells; Mullershausen et al., 2004) as a model.
Restoring the arginine at position 349 led to an obvious
improvement in the fluorescence of cells transfected with the
FlincG clone containing tail B (Figure 1B) and so all further mod-
ifications retained this correction. The effects of variations of the
tail and/or cpEGFP regions were first screened using FACS anal-
ysis of transfected HEKGC/PDE5 cells in the absence and presence
of the membrane-permeating cGMP analogue, 8-bromo-cGMP.
The frequency-fluorescence intensity distributions displayed two
components (Figure 1C). One component (arrows, Figure 1C)
had a similarly low intensity regardless of the cDNA used for
transfection and the other (open arrowheads, Figure 1C) had
a higher, but more variable, fluorescence. The relative fluores-
cence intensity of the two populations also varied with different
FlincGs, with only the broader, brighter population shifting in
the presence of 8-bromo-cGMP. Sham-transfected cells (n = 3)
could be fitted to a single population that coincided with the
low-intensity component (n = 34): the median fluorescence val-
ues (in log arbitrary units) were, respectively, 0.17 ± 0.013 and
0.18 ± 0.004 in the absence of 8-bromo cGMP, and 0.15 ± 0.011
and 0.15 ± 0.007 in its presence. Consequently, the compo-
nents having low 8-bromo cGMP-insensitive fluorescence and
higher 8-bromo cGMP-sensitive fluorescence are taken to repre-
sent untransfected and transfected cell populations, respectively.
Deconvolution of the FACS spectra enabled values for the %
transfection, the median basal fluorescence and the shift in flu-
orescence brought about by 8-bromo cGMP to be quantified (see
Materials and Methods).
None of the alterations substantially affected the transfection
efficiency, which remained at around 80%. Correcting tail B to
the published tail A, producing the variant FGA in the nomen-
clature explained in Figure 1A, resulted in only a small response
to 8-bromo cGMP compared with the version with the uncor-
rected tail B (FGB, Figure 1D), as did complete removal of the
tail (FG, Figure 1D). When the mutations of the cpEGFP region
were imposed alone or in combination on these tail variants, no
consistent pattern emerged. The most notable effect of the M-
mutation (M335K) was on the behavior of FGA (giving FGAM):
on the negative side, the basal fluorescence was low (see, for
example, the relatively small overlap between transfected and
untransfected components of the FACS spectrum in Figure 1C)
but a positive effect was an increase in the amplitude of the
response to 8-bromo-cGMP compared with either FGA or FGB.
The same mutation in FGB had no obvious effect on either basal
fluorescence or 8-bromo-cGMP biosensitivity. On its own, the T-
mutation (T385V) appeared to inhibit biosensing by both FGA
and FGB but with the tailless FG variant, it enhanced basal flu-
orescence. Moreover, in response to 8-bromo-cGMP, the FGT
fluorescence became reduced, rather than increased, an effect also
seen to a lesser extent with theM-mutation (FGM).With the dou-
ble mutant (FGMT), both basal fluorescence and the amplitude of
the dimming in the presence of 8-bromo-cGMP appeared to be
accentuated compared with the single T-mutation. Addition of
the M-mutation also partially or completely compensated for the
inhibitory effect of the T-mutation on the responsiveness of FGA
and FGB.
To test how the effects of these molecular variations would
translate in a more physiological setting, transfected HEKGC/PDE5
cells were superfused (1min) with NO to stimulate endogenous
cGMP generation and the responses recorded using fluorescence
imaging. The NO concentration chosen (1 nM) was one that
gives a maximal response when the cells are infected with ade-
noviral FlincG (Batchelor et al., 2010; Wood et al., 2011). In
general, the pattern of responses of the FlincG variants to NO
recorded at the single-cell level (Figure 2) was similar to that
observed by FACS analysis. Responses to NOwere triphasic, being
composed of a transient peak followed by a prolonged plateau.
This response shape reflects a rapid stimulation of NO-activated
guanylyl cyclase, raising cGMP, and a slow increase in activity of
the cGMP-stimulated phosphodiesterase-5, gradually enhancing
the rate of cGMP hydrolysis (Mullershausen et al., 2004; Halvey
et al., 2009; Batchelor et al., 2010). Within the A-tail series, FGAM
gave the largest response to NO whereas the variant having the
published FlincG domains (FGA) gave only a low-amplitude flu-
orescence change (Figure 2A). In the B-tail series, FGB was the
best sensor (Figure 2B) and the tailless FG group all gave inverted
responses that were largest with FGT and FGMT (Figures 2C,F).
From these results, two of the variants were selected for pro-
tein purification and spectroscopic analysis, and possible crystal
structure determination: FGB, because it was most like the ade-
noviral FlincG and its response in the HEKGC/PDE5 cells resem-
bled that of the adenoviral construct; and FGAM, because of
its superior response amplitude (despite low basal fluorescence).
Enzyme-cleavable hexahistidine tags were added to facilitate pro-
tein purification. The C-terminal tag requires a preceding lysine
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FIGURE 2 | Responsiveness to NO of HEKGC/PDE5 cells transfected with
FlincG variants. (A–E) Representative recordings (from 3 to 4 experiments)
of HEKGC/PDE5 cells transfected with the indicated FlincG variants (grouped
as in Figure 1) and exposed to 1 nM NO for 1min (horizontal bars). Traces
are averages of 5–20 cells; vertical bars are ± SEM. Calibrations (C, bottom)
apply to all panels. (F) Sample brightfield images (“BF”, left), together with
the baseline fluorescence (“Control”, center) and maximal NO-induced
change in fluorescence (“Peak”, right), coded into the grayscale shown on
the extreme right, of cells transfected with H6-FGAM (top) and FGMT
(bottom); scale bar (in the top left image) = 50μm.
residue to render it carboxypeptidase-sensitive and this residue
would remain in the protein following tag removal. As judged
by FACS analysis, adding a lysine to FGB (FGB-K) increased the
median basal fluorescence in HEKGC/PDE5 cells by about 2-fold,
an effect that persisted with the further addition of a hexahis-
tidine tag (FGB-KH6); responses to 8-bromo-cGMP were not
obviously changed by either modification (Figure 1E). Cellular
NO-sensitivity recorded at the single cell level was also unal-
tered (Figure 2D). N-terminal tags were supplied by the pTriEx-4
vector. HEKGC/PDE5 cells transfected with H6-FGB displayed no
major changes in basal fluorescence or in responsiveness to 8-
bromo-cGMP (Figure 1F) and NO (Figure 2E). Unexpectedly,
adding a N-terminal tag to FGAM had a marked effect. In FACS
spectra, the median basal intensity of cells increased almost 7-
fold compared with the untagged version (see Figure 1C) to
become one of the brightest, rather than dimmest, of the vari-
ants. Furthermore, the mean shift with 8-bromo-cGMP was the
largest, amounting to about twice the increase recorded using
FGB (Figures 1C,F). The results of the FACS screen were verified
by single-cell imaging, which showed H6-FGAM to produce the
largest response to superfusion of 1 nM NO (Figures 2E,F).
CHARACTERIZATION OF PURIFIED H6-FGB AND H6-FGAM PROTEINS
The fluorescence spectra of H6-FGB andH6-FGAM proteins were
similar, showing prominent excitation peaks at 410 and 480 nm,
and emission peaks at 510 nm (Figures 3A,B), comparable to the
spectrum reported for the original FlincG (Nausch et al., 2008).
On addition of cGMP, only the major excitation and emission
peaks at 480 nm and 510 nm, respectively, substantially increased
in amplitude, the maximum change with H6-FGAM being 4-
fold larger than with H6-FGB. Concentration-response curves
(Figure 3C) showed that H6-FGB and H6-FGAM proteins were
respectively 120- and 230-fold selective for cGMP over cAMP
(Table 1). The half-maximally effective concentrations (EC50 val-
ues) of cGMP were in the same range for the two biosensors:
0.89μM for H6-FGAM and 0.64μM for H6-FGB, with the Hill
slopes (1.3–1.4)meeting expectations should the protein have two
cGMP-binding sites, both of which need to be occupied for the
conformational change and associated fluorescence increase to
occur (Batchelor et al., 2010). It was also of interest to determine
the potency of 8-bromo-cGMP because this derivative is used to
generate a fluorescent signal in the FACS experiments (see above)
and for testing cGMP biosensors expressed in other cell types (see
below).With bothH6-proteins, 8-bromo-cGMPwasmore potent
than cGMP but the concentration-response curves were shallow,
with Hill slopes of about 0.6 (Figure 3C; Table 1).
EVALUATION OF SELECTED FlincGs AS CELLULAR cGMP BIOSENSORS
From the results obtained above, the properties of four potential
biosensors were scrutinized using the model HEKGC/PDE5 cells.
Those selected for investigation were the two H6-tagged pro-
teins (H6-FGAM and H6-FGB), FGB, and FGMT, the latter being
the tailless variant that dimmed the most in response to cGMP
(and 8-bromo-cGMP). Firstly, concentration-response relation-
ships following superfusion (1min) of NO in clamped concen-
trations were determined. All the biosensors responded in an
NO concentration-dependentmanner with the responses peaking
at about 1 nM NO (Figures 3D,E). Moreover, they all generated
similar triphasic response shapes (see above) at the higher NO
concentrations, suggesting sensitivity of the biosensors to endoge-
nous cGMP in the 0.1–10μM range (Batchelor et al., 2010).
Particularly at the highest concentration (3 nM NO), there was
some cell-to-cell variation in the shape of the response although
the rising phases were closely similar (Figure 3E inset), indicating
that the heterogeneity reflects variations in phosphodiesterase-
5 (rather than guanylyl cyclase) activity (Batchelor et al., 2010).
On re-inspection of the individual cell recordings, a similar vari-
ation was found in the results of an earlier study when these
cells were infected with adenoviral FlincG (Batchelor et al.,
2010). The potency of NO was highest with FGB and H6-FGB
(EC50 = 76 and 104 pM), falling 2- to 3-fold lower with H6-
FGAM and FGMT (EC50 = 190 pM) but the Hill slopes were
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FIGURE 3 | Cyclic nucleotide sensitivity of H6-FGAM and H6-FGB
proteins and NO-sensitivity of HEKGC/PDE5 cells expressing selected
FlincG variants. (A,B) Sample excitation (left) and emission (right)
spectra of H6-FGB (A) and H6-FGAM (B) proteins in the absence
(black) and presence of 1μM (red) and 100μM (blue) cGMP, normalized
to the peaks in the absence of cGMP. (C) Cyclic nucleotide
concentration-response curves for the two proteins. Points are means
of three determinations ± SEM. (D) NO concentration-response curves
in HEKGC/PDE5 cells transfected with the indicated FlincG variants
(n = 3–5). (E) Representative recordings of responses to NO
contributing to panel D. NO concentrations (specified at bottom) were
superfused for the time indicated by the horizontal bars. Traces are
means of 11–24 cells; the calibration (top left) applies to all of them.
The inset illustrates the heterogeneity in the response profile amongst
cells in a given experiment often (but not always) observed at the
higher NO concentrations. Also at the higher concentrations, responses
were sometimes followed by small, rapid undershoots and small, slow
secondary fluorescence increases (or decreases in the case of FGMT,
bottom trace), as was observed previously with adenoviral
FlincG-infected HEKGC/PDE5 cells (Batchelor et al., 2010).
Table 1 | Concentration-response curve parameters for purified FlincG
proteins.
FlincG protein EC50 (µM) nH Rmax
H6-FGAM
cGMP 0.89 ± 0.05 1.36 ± 0.16 1.21 ± 0.02
8-Br-cGMP 0.62 ± 0.23 0.64 ± 0.17 1.29 ± 0.08
cAMP 204 ± 25 1.43 ± 0.18 0.92 ± 0.05
H6-FGB
cGMP 0.64 ± 0.004 1.32 ± 0.01 0.31 ± 0.001
8-Br-cGMP 0.15 ± 0.09 0.60 ± 0.17 0.29 ± 0.01
cAMP 75.4 ± 4.0 1.48 ± 0.08 0.33 ± 0.01
nH is the Hill slope and Rmax the maximum response (F/F0); n = 3.
all similar (Figures 3D,E; Table 2). The most obvious difference
was in the response amplitude, which was in the order H6-
FGAM >>FGB= FGMT >H6-FGB. After averaging, H6-FGAM-
transfected cells detected 10 pM NO in 3 out of 5 experiments
whereas the other biosensors responded to this concentration
once (in 3 or 4 experiments). All the biosensors responded to
30 pM NO in each experiment.
A second series of tests aimed to probe the dynamic respon-
siveness of the two leading cGMP biosensors, FGB and H6-
FGAM, by rapidly administering puffs of NO of varying duration
to transfected cells from a nearby pipette (see Figure 4D). With
1 nM NO in the pipette, puffs lasting 300ms produced detectable
responses through both biosensors, with H6-FGAM again giving
the higher amplitude (Figures 4A,B). The responses increased in
Table 2 | NO concentration-response curve parameters in
FlincG-transfected HEKGC/PDE5 cells.
FlincG EC50 (pM) nH Rmax
H6-FGAM 191 ± 37 1.10 ± 0.09 0.66 ± 0.03
H6-FGB 104 ± 25 1.26 ± 0.19 0.18 ± 0.01
FGB 76 ± 12 1.45 ± 0.18 0.25 ± 0.02
FGMT 190 ± 14 1.36 ± 0.09 −0.26 ± 0.005
nH is the Hill slope and Rmax the maximum response (F/F0); n = 3–5.
size with longer puffs, reaching a peak with 10-s applications,
when the fluorescent increase with H6-FGAM was almost 3-fold
higher than with FGB. Half-maximum responses corresponded
to a puff duration of about 1.3 s for both biosensors (Figure 4C).
With H6-FGAM, the peak response with a long (30-s) puff was
lower than with a shorter (10-s) one, whereas the amplitudes of
the two were the same with FGB. This result is expected from
H6-FGAM having a lower cGMP affinity than FGB (Table 1): the
sequence of 1 nM NO applications leads to a progressive build-
up of activated phosphodiesterase-5 which results in lower cGMP
concentrations during the 30-s application than during the pre-
ceding 10-s application; a lower-affinity biosensor would register
this fall whereas the higher-affinity biosensor would remain sat-
urated (see Figure 5 of Batchelor et al., 2010). In all cases, the
timing of the response onset and start of recovery coincided with
the arrival and disappearance of NO, after allowing for its dif-
fusion through unstirred layers surrounding the cells (Batchelor
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FIGURE 4 | Comparison between H6-FGAM and FGB as sensors of NO
puffs when expressed in HEKGC/PDE5 cells. (A,B) Representative traces
of fluorescence changes to NO puffs of different durations (black traces);
the NO applications are quantified from the Texas Red dye intensity (red
traces), with the applied durations specified underneath. There was a 5-min
interval between applications and each result is from a single cell.
Calibration (in B) applies to both sets of data. (C) Mean responses (± SEM)
to the different puff durations in four (H6-FGAM) or seven (FGB) cells in
three experiments. (D) Images showing the spread of Texas Red from the
puffer pipette (top) within a field of cells (brightfield, middle), two of which
are fluorescent (bottom); the arrowed cell is the source of the traces in (B);
scale bar (middle) = 50μm.
et al., 2010), indicating that the kinetic properties of the two
biosensors are immeasurably fast at these subsecond time-scales.
SENSITIVITY TO pH
The classical intracellular pH modifier, NH4Cl (1–10mM), was
perfused onto HEKGC/PDE5 cells transfected with FGB. An
increase in fluorescence occurred that waned gradually dur-
ing the exposure (Figure 5A). On washout, the fluorescence fell
below the resting level and then recovered slowly. The shapes
of these responses closely resemble the usual NH4Cl -induced
alkalinization and after-acidification of intracellular pH (Roos
and Boron, 1981). For a more direct test, the cells were treated
with a mixture of ionophores (nigericin plus CCCP) that result
in the equalization of intracellular and extracellular pH (Kneen
et al., 1998). In a sample experiment (Figure 5B) titration of
the pH between 8.5 and 5.5 led to marked changes in FGB flu-
orescence that were up to 10-fold larger than that generated
previously (via cGMP) by a maximally effective concentration
of NO and that were half-maximal at around pH 7.5. The other
FlincG variants tested in this way, namely H6-FGAM and FGMT
(which dims in response to cGMP) showed similar pH sensitiv-
ity (Figure 5C), with apparent pKa values of about 7.5 andF/F0
dynamic ranges of 4.7–8.5 (Table 3). The sensitivity to alkaline
shifts was much higher than that of EGFP (F/F0 = 0.36 at
pH 8.5; Figure 5C). From the calibrations, the peak responses to
NH4Cl in intact FGB-transfected HEKGC/PDE5 cells (Figure 5A)
correspond approximately to increases in intracellular pH of 0.04
units (1mM NH4Cl), 0.21 units (3mM) and 0.4 units (10mM).
These changes are consistent with 20mM ammonia raising the
pH of HEK293T cells by about 1 unit (Schuhmann et al., 1997;
Lang et al., 2003).
The pH sensitivity of purified H6-FGAM and H6-FGB pro-
teins was assessed with and without a saturating concentration of
cGMP (100μM) using spectrofluorometry. With both proteins,
the excitation peak at 480 nm was highly pH-sensitive, as was the
emission peak at 510 nm (Figure 5D). Titration curves showed
apparent pKa values of 7.9 and 7.5 for H6-FGAM and H6-FGB,
respectively, in the absence of cGMP (Figures 5E,F; Table 4). In
the presence of cGMP, both curves shifted in the acidic direction,
the shift with H6-FGAM being larger than with H6-FGB. The net
result was that the pH giving the maximal cGMP-induced change
in fluorescence (F/F0) was lower for H6-FGB (pH 6.0) than for
H6-FGAM (pH 7.0). The larger response of H6-FGAM to cGMP
seen previously at pH 7.5 (Figure 3C; see also Figure 3E for cell
data) also applied at the pH optima, where the peak F/F0 of
H6-FGAM was twice that of H6-FGB (Figures 5E,F).
TRANSFECTION OF NEURAL CELLS
Considering the disappointing transfection efficiency observed at
the outset with the AdV-FlincG DNA plasmid, tests were car-
ried out to determine if the superior properties of the FlincG
variants in HEKGC/PDE5 cells translated into greater versatility
of transfection, particularly for neurones which pose particular
difficulties in this regard. As a first step, we attempted to trans-
fect differentiated N1E-115 neuroblastoma cells with FGB. These
cells have long been known to generate cGMP on stimulation
of cholinergic and other receptors (Matsuzawa and Nirenberg,
1975; Saito and Deguchi, 1979), effects now known to be medi-
ated through endogenous NO formation (Hu and El-Fakahany,
1993). The transfection was routinely successful with around
25% of cells showing strongly fluorescent cell bodies and more
weakly fluorescent neurites (Figure 6A). On superfusion of NO
in clamped concentrations (0.1–3 nM), the fluorescence increased
and then recovered back to baseline on washout; the NO EC50
was approximately 100 pM (Figure 6B). Responses to 1 nM NO
were repeatable (Figure 6C) and were abolished by the inhibitor
of NO-activated guanylyl cyclase ODQ (Figure 6D), confirm-
ing mediation by cGMP. On superfusion of acetylcholine to
elicit endogenous NO synthesis, the fluorescence increased but
then faded during the application (after about 1min) to fall
below baseline, before recovering on washout of acetylcholine
(Figure 6E). In the presence of the NO synthase inhibitor, L-
nitroarginine (30μM), the increase in fluorescence was abol-
ished, but a small undershoot remained. The undershoots seen
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FIGURE 5 | Sensitivity of FlincG variants to pH. (A) Responses of
HEKGC/PDE5 cells expressing FGB to 2-min applications of NH4Cl
(horizontal bar). Traces are means from 40 cells; vertical bars are ± SEM.
(B) HEKGC/PDE5 cells expressing FGB were initially stimulated with NO
(1 nM; 1min), after which the combination of CCCP (20μM) and nigericin
(10μM), which results in an equalization of intracellular and extracellular
pH, was superfused at different pH values (as indicated by the stepped
horizontal bars below). The trace is the average of 10 cells; vertical bars
are ± SEM. (C) Summary pH titration data obtained as in panel (B) on
HEKGC/PDE5 cells expressing different FlincGs or EGFP (n = 3). (D)
Sample excitation (Ex) and emission (Em) spectra of purified H6-FGAM
and H6-FGB proteins in the absence (solid lines) or presence (dashed
lines) of 100μM cGMP, at pH 6.5 (red), 7.5 (green) and 8.5 (blue),
normalized to the peak at pH 8.5 in the absence of cGMP. (E,F)
pH-titration data for the fluorescence (arbitrary units) of the purified
FlincG proteins in the absence and presence of 100μM cGMP (left-hand
ordinate), and the dynamic ranges, expressed as F/F0, at each pH
(black squares; right-hand ordinate).
Table 3 | pH-sensitivity parameters in FlincG-transfected HEKGC/PDE5
cells.
FlincG pK′a nH A B
FGAM 7.63 ± 0.05 0.93 ± 0.04 −0.68 ± 0.02 8.45 ± 0.43
FGB 7.56 ± 0.03 1.01 ± 0.02 −0.86 ± 0.005 5.88 ± 0.18
FGMT 7.41 ± 0.02 0.86 ± 0.02 −0.91 ± 0.008 4.73 ± 0.09
EGFP 6.33 ± 0.03 0.94 ± 0.04 −1.01 ± 0.03 1.38 ± 0.04
pK′a is the apparent pKa, nH, the Hill slope; A and B are constants in the titration
equation given in material and methods and correspond to the baseline of the
curve (A) and the F/F0 dynamic range (B); n = 3.
Table 4 | pH-sensitivity of purified FlincG proteins.
FlincG protein pK′a nH
H6-FGAM
Control 7.94 ± 0.07 1.20 ± 0.20
cGMP (100μM) 7.53 ± 0.08 0.91 ± 0.15
H6-FGB
Control 7.48 ± 0.05 1.51 ± 0.24
cGMP (100μM) 7.33 ± 0.06 1.41 ± 0.25
pK′a is the apparent pKa and nH the Hill slope.
with and without L-nitroarginine possibly reflect a transient cell
acidification being registered by the biosensor (Seo et al., 1994;
Wood et al., 2011). Superfusion of a high concentration of the
NO donor PAPA/NO (100 nM) at the end of the experiment
(Figure 6E) indicated that the peak acetylcholine-evoked increase
in fluorescence corresponded to about half the maximum ampli-
tude or, from Figure 6B, about 100 pM NO.
In the light of these positive results with neuroblastoma cells,
pilot experiments were carried out on primary cultures of rat
hippocampal and dorsal root ganglion (DRG) cells. Despite min-
imal attempts at optimization, cells of different types in mature
hippocampal cultures were successfully transfected with FGB:
Figure 6F shows a putative oligodendrocyte, neurone and astro-
cyte fluorescing in a single field of cells. On superfusion of
8-bromo-cGMP these cells all responded, signifying that they
expressed a functional cGMP biosensor.
The DRG cultures comprised varying sized neurones hav-
ing prominent rounded cell bodies accompanied by a back-
ground of glia (satellite cells and Schwann cells) and fibroblasts
(Figure 7A), as is normally found in these cultures (Fields et al.,
1978). We attempted to transfect the cells with H6-FGAM and,
to check results with HEKGC/PDE5 cells (Figure 1B), also with
AdV-FlincG plasmid DNA. No fluorescence above background
was detected with AdV-FlincG plasmid DNA and, on superfusion
of 8-bromo-cGMP, only a continuing bleaching of the autoflu-
orescence was recorded (Figures 7A,B), implying that the cells
lacked a functional biosensor.WithH6-FGAM, on the other hand,
neurones (and non-neuronal cells; see below) were clearly trans-
fected (Figure 7Ac) and they responded to 8-bromo-cGMP with
a slow increase in fluorescence (Figure 7B), ultimately reach-
ing amplitudes comparable to those seen with this biosensor
in HEKGC/PDE5 cells exposed to maximal NO stimulation (e.g.,
Figure 3D). With higher-power imaging, neuronal processes
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FIGURE 6 | Expression of FGB in differentiated N1E-115 neuroblastoma
cells (A–E) and rat hippocampal cell cultures (F,G). (A) Brightfield (left)
and fluorescent (right) images of neuroblastoma cells (two transfected, two
untransfected); scale bar = 50μm. (B) Response to increasing clamped
NO concentrations applied at the horizontal bars (5 cells). (C) Response to
three consecutive 1 nM NO applications followed by 3 nM NO (10 cells).
(D) Inhibition of the response to 1 nM NO by ODQ (8 cells). (E) Response
to acetylcholine (ACh) in the absence and presence of L-nitroarginine
(L-NNA) with application of a high concentration of PAPA/NO at the end (4
cells). Blue lines in B-E are means; gray lines = SEM. (F) Brightfield (left)
and fluorescent (right) images of a rat hippocampal cell culture. Cells
numbered 1, 2, and 3 are a putative oligodendrocyte, neurone and
astrocyte, respectively, based on their morphology. Scale bar = 50μm. (G)
Responses of these 3 cells to superfusion of 8-bromo-cGMP.
could be discerned (Figure 7C), although their baseline fluores-
cence was relatively low, reflecting their thinness. On perfusion
of 8-bromo-cGMP, the fluorescence of the processes increased
along their visible lengths (see below). Varicosities, approximately
1–2μm in diameter, responded more obviously and with a fluo-
rescence change of similar amplitude to, but faster than, that seen
in the soma, (Figure 7D).
NO and a member of the natriuretic peptide family, namely
C-type natriuretic peptide (CNP), are both important signaling
molecules for DRG neurones, particularly during their devel-
opment: NO provides neuroprotection by elevating cGMP in
Schwann cells, resulting in the release of neurotrophic factors
(Thippeswamy et al., 2005) whereas CNP contributes to the
growth of axons and their connectivity within the spinal cord
(Schmidt et al., 2007; Kishimoto et al., 2008; Zhao andMa, 2009).
CNP acts through natriuretic peptide receptor-2, a membrane-
spanning guanylyl cyclase-coupled receptor expressed in DRG
neurones (Schmidt et al., 2007; Kishimoto et al., 2008). To test
the ability of H6-FGAM to register agonist-induced cGMP ele-
vations in DRG cells, saturating concentrations of PAPA/NO
(1μM) or CNP (1μM) were superfused (1min). Responses
were elicited from almost every transfected cell examined (9/11
and 12/12 cells, respectively; 8 coverslips, 2 separate platings),
whether they were neuronal (Figure 7E) or non-neuronal in
appearance (Figure 7F). Responsiveness of both cell populations
to NO in DRG cultures agrees with a previous report using
cGMP immunocytochemistry (Thippeswamy and Morris, 2001).
In the 15 cells where both agonists were applied 20–30min apart,
the relative response amplitudes differed in an unsystematic way
(Figures 7F,G) but, in all instances, the decay was slow, taking
3–5min after agonist washout for the baseline to be resumed.
A neurone having a long (>100μm) neurite that remained
physically stable during the recording period was fortuitously
captured in one field (Figure 7G). Responses to both PAPA/NO
and CNP were seen in the soma and along the length of the
neurite, and were consistently larger with PAPA/NO than with
CNP. The amplitudes increased progressively with distance from
the soma (reaching a 1.5-fold change with PAPA/NO), a find-
ing that may partially be related to a progressively diminishing
basal fluorescence, which became close to background at the most
distal point. The results indicate that, at least at high concen-
tration, NO and CNP may have multiple cellular targets in the
DRG, all of which appear to exhibit low cGMP phosphodiesterase
activity, thereby allowing global build-up of cGMP irrespective
of the presumably different subcellular locations (cytosolic vs.
membrane-associated) of its synthetic enzymes.
DISCUSSION
In an attempt to generate a useful cDNA plasmid for cGMP
biosensing in a variety of cell types, it transpired that the aden-
oviral FlincG, which has allowed successful recordings of cGMP
signals in smooth muscle, HEK293T cells and cardiac fibroblasts
(Nausch et al., 2008; Batchelor et al., 2010; Miller et al., 2011;
Wood et al., 2011), and a plasmid FlincG, both kindly provided
to us by the originator laboratory, coded for a sequence that dif-
fered from the one that they originally reported (Nausch et al.,
2008). In evaluating the importance of the differences, restora-
tion of an arginine (from cysteine) in the cpEGFP region was of
clear benefit for expressing a functional biosensor in HEK293T
cells using a cDNA plasmid. When driven by the adenoviral
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FIGURE 7 | Expression of H6-FGAM in DRG cultures. (A) (a) Brightfield
image of a typical culture showing neurones of different sizes and an
underlay of flatter, glial-like cells. (b,c) Fluorescence images of cultures
after attempted transfection with AdV-FlincG plasmid DNA (b) and
H6-FGAM (c) and exposure to 1mM 8-bromo-cGMP for 10min. Scale bar
(a) = 50μm. (B) Time-courses of fluorescent changes in the individual
cells arrowed in (Ab) and (Ac) during superfusion of 8-bromo-cGMP. (C)
High-power brightfield (a) and fluorescence (b,c) images of a transfected
neurone before (b) and after (c) superfusion of 8-bromo-cGMP (1mM) for
8min. The images in (b) and (c) were processed identically. Scale bar (a) =
25μm. (D) Time-course of the changes in fluorescence in the
number-coded puncta and cell soma demarcated in red in (c). Relatively
large regions of interest were used for the puncta to accommodate their
movement during the experiment. This procedure should not have affected
the signal amplitude but may have increased the noise. (E–G) Neuronal
(E,G) and glial-like (F) cells transfected with H6-FGAM and exposed to
PAPA/NO (E) or PAPA/NO followed 20–30min later by CNP (F,G). Each
panel (E–G) shows pairs of brightfield (a) and fluorescent (b) images; scale
bars = 25μm. Traces (c) are from the regions outlined in red in (b); black
horizontal bars = periods of agonist application; in (E) only one punctum (at
the top) was analyzed because the others, despite obviously responding,
were too motile; calibrations in (Fc) also apply to the traces in (Ec).
vector, a higher protein expression may compensate for this dis-
advantageous mutation. It is unclear how the mutation arose
but, according to the distributer’s website (Addgene: http://www.
addgene.org/), it is present in DNA sequences for all the original
FlincG variants (α-, β- and δ-FlincG).
The other region of concern was in the 17-amino acid C-
terminal tail which, apart from the first 3 amino acids, was
different from the stated sequence. Again, this divergent tail
appears in all the sequences deposited in the distributor’s website.
The change from the bovine PKG sequence could be explained
by two point mutations: deletion of a cytosine in the fourth
codon (altering the reading frame and creating a premature stop
codon) together with a mutation in the triplet immediately pre-
ceding this stop codon. The authors state that extending this
tail to include the PKG catalytic domain or complete removal
of the tail had no effect on overall fluorescent intensity changes
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(Nausch et al., 2008). In contrast, we find the tail region to have
a major effect on cGMP biosensing, such that restoring the “cor-
rect” PKG sequence (in the absence of further modification) gave
only poor responsiveness to cGMP (or 8-bromo-cGMP), as did
its complete removal. Thus, on this evidence, the “incorrect” tail
(tail B) appears to be superior. By analogy with inferences made
for GCaMP3 (Tian et al., 2009), one explanation might be that
tail B codes for a nuclear exclusion sequence [L(X)2−3L(X)2−3L;
(Bogerd et al., 1996; la Cour et al., 2004)] but, as variants lacking
a tail (i.e., FGT and FGMT) and one variant with the “correct” tail
(H6-FGAM) functioned at least as well as FGB, this explanation
appears inadequate.
In addition to the importance of the tail region, a second dis-
crepancy between our results and the original report on FlincG
(Nausch et al., 2008) concerns pH sensitivity. The authors of
this report claim that FlincG is insensitive to pH in the physio-
logical range because of its low pKa (6.1) but this conclusion is
drawn from a plot of the cGMP-induced changes in fluorescence
at different pH values (their Supporting Information Figure 7),
so that information on how basal fluorescence varies with pH
is lost. Our results both with transfected cells and purified pro-
teins show that basal fluorescence is highly pH-dependent, giving
apparent pKa values of about 7.5. In this respect, our data are in
good agreement with expectations from the properties of cpEGFP,
whose apparent pKa is reported as 7.7 (Akemann et al., 2001)
and 7.4 (Wang et al., 2008). Indeed, the more physiological pH
optimum displayed by H6-FGAM for the cGMP-induced fluo-
rescence increase (compared with H6-FGB; Figures 5E,F) helps
explain its superior dynamic range when expressed in cells. For
example, assuming HEK293T cells have an intracellular pH of
7.5 (Willoughby et al., 2005), the maximum cGMP-induced flu-
orescence change (F/F0) for H6-FGB and H6-FGAM would be
0.22 and 0.94, respectively, based on protein data while the max-
imum changes in NO-stimulated HEKGC/PDE5 cells amounted
to 0.18 and 0.66, respectively. The values are in good agree-
ment (both about 4-fold different) bearing in mind that the cell
responses are expected to be of lower amplitude because they
were measured with broader band-pass filter sets compared with
the monochromator-controlled slit-width used for the purified
proteins. At the lower pH values of 7 and 6.5, the relative max-
imum fluorescence changes of the two sensors should differ less,
by 3-fold and 2-fold, respectively (from Figures 5E,F).
Clearly, just as with other cpEGFP-based biosensors, such as
GCaMPs (Nakai et al., 2001; Wang et al., 2008; Zhao et al.,
2011), it is important to be mindful of pH-induced artifacts
in live cell imaging. As a case in point, using FGB-transfected
HEKGC/PDE5 cells as detectors for NO released from NMDA-
stimulated brain slices, we observed fluorescent undershoots that
were NO-independent and attributed to transient acidifications
brought about by products of metabolic stimulation, notably
lactate (Wood et al., 2011). The small NO-independent under-
shoots observed in neuroblastoma cells exposed to acetylcholine
(Figure 6E) might have a similar origin.
We also examined the effect of M- and T-mutations that con-
tributed to the engineering of GCaMP3 from GCaMP2 (Tian
et al., 2009), and the interaction of these mutations with the
type of tail. In the structure of GCaMP2, the T-residue (T116)
faces the inside of the β-barrel of cpEGFP and thus directly
influences the protonation state of the chromophore (Wang et al.,
2008). Mutating this residue to valine increases excited-state pro-
ton transfer in EGFP (Kummer et al., 2000) and enhances the
fluorescent response of GCaMP2 to Ca2+ by 2-fold (Akerboom
et al., 2009). On its own, the T-mutation in FlincG variants had
a deleterious effect on the responsiveness to cGMP with both
tail types, but enhanced the cGMP-induced dimming of the tail-
less variant (FG). The M-residue faces outside the β-barrel and
mutating it to a hydrophilic residue was originally one of the
cycle-3 GFP mutations that improved brightness and reduced
aggregation (Crameri et al., 1996). One of the other two cycle-
3 mutations (V164A) is already retained in the cpEGFP region of
GCaMP2/3 and FlincG. Again, the M-mutation in FlincG vari-
ants offered little obvious improvement, with the exception of the
variant with the “correct” tail A (i.e., FGAM) which gave enhanced
cGMP response amplitudes. With double mutations, the only
notable benefit was in the amplitude of dimming of the tailless
variant (FGMT). Altogether, our results point to a lack of general-
izability of the effect of mutations across FlincG variants, and an
inability to extrapolate findings with GCaMPs to other cpEGFP-
based biosensors, although in specific cases one or bothmutations
can lead to improvements. Obviously, structural information is
needed to interpret the effects of the mutations mechanistically
but, unfortunately, initial attempts at obtaining protein crystals
(with H6-FGAM) were not successful.
Finally with respect to the development of FlincG-based
biosensors, the attachment of an N-terminal tag (comprising a
hexahistidine tag, Protein S-tag and an enterokinase cleavage site)
led to an unexpected improvement in one of the variants (FGAM).
Importantly, the tag seemed solely to enhance basal fluorescence
(which was unusually low without the tag), without compromis-
ing functional responsiveness. A beneficial effect of an N-terminal
tag, in this case supplied by the vector pRSET, has also been
reported for GCaMP2, its effect being attributed to an enhanced
thermal stability at 37◦C (Tallini et al., 2006). Although the tag we
used is different from the pRSET version (but both plasmids sup-
ply a hexahistidine tag), our observations are consistent with such
an interpretation and, while the variant is named H6-FGAM, it is
not necessarily the hexahistidine tag that confers the advantage.
In evaluating the potential utility of the improved FlincG vari-
ants, the main criteria are high sensitivity and selectivity for
cGMP, high basal fluorescence, high signal-to-noise ratio, and
rapid kinetics. In terms of the latter, there was no evidence that the
kinetics of any of the biosensors was rate-determining, although
the most rigorous testing (brief puff applications of NO) was car-
ried out only on the two leading variants. Hence, the modified
biosensors are likely to operate at least as rapidly as the origi-
nal FlincG (Nausch et al., 2008; Batchelor et al., 2010). Based on
all the above criteria, two of the variants (FGB and H6-FGAM)
showed particular promise in the model HEK293T cells. A third
variant, FGMT, is also potentially interesting in that it shows
high basal fluorescence that dims in the presence of cGMP but
the maximum response amplitude was no better than with FGB.
While we have not determined the potency of cGMP on FGB
directly, the EC50 for NO (76 pM) in HEKGC/PDE5 cells was essen-
tially identical to the value obtained using the original FlincG in
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the same cells (70 pM; Batchelor et al., 2010; Wood et al., 2011),
implying a similar affinity for cGMP (EC50 = 0.17μM; Nausch
et al., 2008), whereas the EC50 for cGMP on H6-FGAM was
5-fold lower at 0.89μM (Table 1). Consistent with cGMP also
having a lower potency for H6-FGAM in cells, the EC50 for NO
in HEKGC/PDE5 cells was shifted upwards to 190 pM and, unlike
FGB, the biosensor registered the fall in cGMP response ampli-
tude taking place at the end of the NO puff-application sequence
(Figure 4B). Assuming the associated changes in cGMP are phys-
iological, the lower affinity biosensor, which saturates at about
10μM cGMP, may be preferable to the original FlincG, which
saturates at about 2μM cGMP. Moreover, because of the larger
change in fluorescence of H6-FGAM, the detectability of small
changes in cGMP is minimally compromised, as was evident
with the subsecond puff applications of NO (Figure 4). When
added to its higher basal fluorescence and the maintenance of a
good selectivity over cAMP (230-fold), these considerations point
to H6-FGAM being the leading biosensor. A possible disadvan-
tage compared with the original FlincG, however, is the lack of
dimming of the secondary excitation peak at 410 nm in the pres-
ence of cGMP (Figure 3B) that could have enabled ratiometric
measurements (Nausch et al., 2008).
Beyond their behavior in model HEK293T cells, the key issue
is the applicability of the biosensors to other cell types, including
neurones. In neuroblastoma cells, the time-courses of responses
to exogenous NO and acetylcholine reported by FGB were closely
comparable to the dynamics of cGMP measured using a patch-
cramming technique (Trivedi and Kramer, 1998, 2002). The
observed saturation of biosensor responses at the higher NO
concentrations (1 nM and above) is also consistent with cGMP
attaining the low micromolar concentrations that were recorded
using patch-cramming in response to an NO-donor, although
the NO concentrations in those experiments were unknown.
The similarities give confidence that the biosensor is faithfully
reporting changes in cGMP concentration. The successful expres-
sion of functionally-active genetically-encoded biosensors (FGB
or H6-FGAM) in primary cultures of hippocampal and DRG cells
with sufficient brightness to enable imaging of small subcellu-
lar domains, opens the way to investigate cGMP-mediated signal
transduction in native cells in vitro and potentially in vivo, with
unsurpassed spatial and temporal resolution.
Finally, we would like to propose a simplified FlincG nomen-
clature (also adopted in the Abstract of this report). The originally
published δ-FlincG sequence with part of PKG as the C-terminal
tail and no mutations in the cpEGFP domain (Figure 1b of
Nausch et al., 2008) would be FlincG1. The biosensor actually
used in that same study, however, appears to be most similar
to FGB with an arginine-to-cysteine mutation in the cpEGFP
domain. We propose that FGB be called FlincG2 and that H6-
FGAM becomes FlincG3.
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